Related references
Note: Only part of the references are listed.Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference
Niklas Thon et al.
JOURNAL OF NEUROLOGY (2017)
ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA
Michael Weller et al.
NEURO-ONCOLOGY (2017)
Prospect of rindopepimut in the treatment of glioblastoma
Aladine A. Elsamadicy et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Susana Inoges et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Immune microenvironment of gliomas
Anna Gieryng et al.
LABORATORY INVESTIGATION (2017)
The heat-shock protein/chaperone network and multiple stress resistance
Pierre Jacob et al.
PLANT BIOTECHNOLOGY JOURNAL (2017)
New Approaches in Glioblastoma Multiforme: The Potential Role of Immune-check Point Inhibitors
Francesca De Felice et al.
CURRENT CANCER DRUG TARGETS (2017)
Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine
D. H. Heiland et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Hanwen Bai et al.
NATURE GENETICS (2016)
PD-L1 expression and prognostic impact in glioblastoma
Edjah K. Nduom et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy
Anirudh Saraswathula et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
Robert A. Fenstermaker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang et al.
CANCER LETTERS (2016)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
Survival in glioblastoma: a review on the impact of treatment modalities
P. D. Delgado-Lopez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
Roy Rampling et al.
CLINICAL CANCER RESEARCH (2016)
Adoptive immunotherapy for the treatment of glioblastoma: progress and possibilities
Shunichiro Kuramitsu et al.
IMMUNOTHERAPY (2016)
The present status and future prospects of peptide-based cancer vaccines
Masatoshi Hirayama et al.
INTERNATIONAL IMMUNOLOGY (2016)
Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism
Tammy Hennika et al.
JOURNAL OF CHILD NEUROLOGY (2016)
Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme
Igor S. Bryukhovetskiy et al.
MOLECULAR MEDICINE REPORTS (2016)
Epidemiology of Brain Tumors
Katharine A. McNeill
NEUROLOGIC CLINICS (2016)
Peptide vaccination therapy: Towards the next generation
Tomohide Tsukahara et al.
PATHOLOGY INTERNATIONAL (2016)
Heat Shock Proteins Promote Cancer: It's a Protection Racket
Stuart K. Calderwood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
The Janus Face of Death Receptor Signaling during Tumor immunoediting
Eimear O' Reilly et al.
FRONTIERS IN IMMUNOLOGY (2016)
Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of Cancer
Maxim Shevtsov et al.
FRONTIERS IN IMMUNOLOGY (2016)
Adjuvants for peptide-based cancer vaccines
Hiep Khong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model
Mao Ouyang et al.
PLOS ONE (2016)
Immune Evasion Strategies of Glioblastoma
Seyed-Mostafa Razavi et al.
FRONTIERS IN SURGERY (2016)
Size dependent classification of heat shock proteins: a mini-review
Hyunseok Jee
JOURNAL OF EXERCISE REHABILITATION (2016)
Conformational Nanobodies Reveal Tethered Epidermal Growth Factor Receptor Involved in EGFR/ErbB2 Predimers
Damien Nevoltris et al.
ACS NANO (2015)
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
Manfred Westphal et al.
EUROPEAN JOURNAL OF CANCER (2015)
Heat shock protein vaccines against glioblastoma: from bench to bedside
Leonel Ampie et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma
Keiichi Sakai et al.
JOURNAL OF NEUROSURGERY (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
David A. Reardon et al.
NEURO-ONCOLOGY (2015)
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
James Schuster et al.
NEURO-ONCOLOGY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro
Igor Stepanovich Bryukhovetskiy et al.
ONCOLOGY LETTERS (2015)
The progress of immunotherapy for glioblastoma
Qiangyi Zhou et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment
Kar Wai Tan et al.
ONCOIMMUNOLOGY (2015)
Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
Yafei Hou et al.
Journal for ImmunoTherapy of Cancer (2015)
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
Martin K. Hunn et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Afferent and efferent immunological pathways of the brain. Anatomy, Function and Failure
R. O. Carare et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
To the Novel Paradigm of Proteome-Based Cell Therapy of Tumors: Through Comparative Proteome Mapping of Tumor Stem Cells and Tissue-Specific Stem Cells of Humans
Andrey Bryukhovetskiy et al.
CELL TRANSPLANTATION (2014)
Heat Shock Proteins as Prognostic Markers of Cancer
Evgeniya V. Kaigorodova et al.
CURRENT CANCER DRUG TARGETS (2014)
Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents
Giulio Tosti et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Development and Function of Dendritic Cell Subsets
Alexander Mildner et al.
IMMUNITY (2014)
Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70
Maxim A. Shevtsov et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
Eiichi Ishikawa et al.
JOURNAL OF NEUROSURGERY (2014)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Orin Bloch et al.
NEURO-ONCOLOGY (2014)
CTL responses to HSP47 associated with the prolonged survival of patients with glioblastomas
Zhe Bao Wu et al.
NEUROLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Fas, FasL, and cleaved caspases 8 and 3 in glioblastomas: A tissue microarray-based study
Fabiano P. Saggioro et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Human Leukocyte Antigen-G Is Frequently Expressed in Glioblastoma and May Be Induced in Vitro by Combined 5-Aza-2′-Deoxycytidine and Interferon-γ Treatments Results from a Multicentric Study
Isabela J. Wastowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Einar Osland Vik-Mo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
Courtney A. Crane et al.
CLINICAL CANCER RESEARCH (2013)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients
Robert M. Prins et al.
JOURNAL OF IMMUNOTHERAPY (2013)
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
Yasuto Akiyama et al.
BMC CANCER (2012)
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Hilko Ardon et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
A. Gregory Sorensen et al.
CANCER RESEARCH (2012)
Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
X. Jie et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
Thierry Gorlia et al.
EUROPEAN JOURNAL OF CANCER (2012)
A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
John H. Sampson et al.
PLOS ONE (2012)
Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
Der-Yang Cho et al.
WORLD NEUROSURGERY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
Robert M. Prins et al.
CLINICAL CANCER RESEARCH (2011)
Heat shock protein-peptide complex in the treatment of glioblastoma
Alfred P. See et al.
EXPERT REVIEW OF VACCINES (2011)
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
Chen-Nen Chang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
John H. Sampson et al.
NEURO-ONCOLOGY (2011)
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Jennifer L. Clarke et al.
NEURO-ONCOLOGY (2011)
Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?
Leos Kren et al.
NEUROPATHOLOGY (2011)
Postoperative Infection May Influence Survival in Patients With Glioblastoma: Simply a Myth?
Pasquale De Bonis et al.
NEUROSURGERY (2011)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
Hilko Ardon et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma†
Myrna R. Rosenfeld et al.
NEURO-ONCOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vitespen: a preclinical and clinical review
Christopher G. Wood et al.
FUTURE ONCOLOGY (2009)
Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder
Timothy P. Kresowik et al.
IMMUNOTHERAPY (2009)
Microglia: gatekeepers of central nervous system immunology
Bart R. Tambuyzer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
John H. Sampson et al.
MOLECULAR CANCER THERAPEUTICS (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
Christopher J. Wheeler et al.
CANCER RESEARCH (2008)
Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
David G. Walker et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines
Robert J. Schmittling et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
Hideho Okada et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
The heat shock response and Chaperones/Heat shock proteins in brain tumors: Surface expression, release, and possible immune consequences
Michael W. Graner et al.
JOURNAL OF NEUROSCIENCE (2007)
Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients
Eiichi Ishikawa et al.
CANCER SCIENCE (2007)
T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa
Jana Goldmann et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
The natural history of EGFR and EGFRvIII in glioblastoma patients
AB Heimberger et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma
AB Heimberger et al.
NEUROSURGERY (2002)
Expression and functional activity of heat shock proteins in human glioblastoma multiforme
M Hermisson et al.
NEUROLOGY (2000)
Share Paper
